WeChat Share

Details

Welcome to the Boston Bioforum 2018-Chinese American BioMedical Association (CABA) Annual Conference. The theme of this year's annual conference is: Catching the Wave: Trends and Disruptive Technologies in Biomedical R&D. There are 4 focusing areas this year: cell and gene therapy, trends in biomedical research, investment across borders, and career path in the US and China. 

 

Date & Time:     8:00 am to 9:00 pm, May 19th, 2018

Venue:                     Boston Marriott Newton, 2345 Commonwealth Avenue, Newton, MA 02466

Theme:                    Catching the Wave: Trends and Disruptive Technologies in Biomedical R&D

Focus:             Cell & Gene Therapy, Trends in Biomedical Research (Immuno-oncology, AI, Biologics)

                                            Investment across borders, Career Path in US and China


8:00 am - 9:00 am             REGISTRATION / VENDOR SHOW

9:00 am - 9:10 am             OPENING REMARKS

Bo Ying, PhD, Conference Chair

9:10 am - 9:30 am             INTRODUCTION OF CABA

Kevin Fang, PhD, President, CABA


9:30 am - 12:00 pm     SESSION I - CELL & GENE THERAPY

Cellframe, a Revolutionary Organ Regeneration Platform

William Fodor, PhD, Chief Scientific Officer, Biostage


Meeting the Challenge of Manufacturing Advanced Therapies: Cell Therapies, Gene-Mediated Cell Therapies and Viral Vectors

Felix Hsu, MBA, SVP, Head of WuXi Advanced Therapies


The Enlightenment of Regenerative Medicine: Convergence of Evolutionary and Revolutionary Approaches

Chris Gemmiti, PhD, Co-founder and CEO, RedactBio, Inc.


Current and Emerging Innovation in Cell and Gene Therapy for Oncology

Paul E Juniewicz, PhD, Senior Director, Oncology Search & Evaluation, Center for External Innovation, Takeda


CRISPR/Cas9 – In Vivo and Ex Vivo Applications to Treat Genetic Diseases, Cancer and Autoimmunity

Birgit Schultes, PhD, VP of Immunology, Intellia Therapeutics Inc.


12:00 pm - 1:00 pm     LUNCH / VENDOR SHOW / CAREER FAIR

CONCURRENT SESSION     CAREER DEVELOPMENT ROUND-TABLE


1:00 pm - 3:00 pm     SESSION II – TRENDS IN BIOMEDICAL RESEARCH


Development of First-in-Class Immuno-Oncology Therapy Through Global Collaboration

Zhihong Chen, PhD, VP, Biology, Adlai Nortye Biopharma Inc.


Creating an Effective, AI-driven Company for Drug Development on the Cloud

Yide Alan Jiang, PhD, Chief Strategic Officer, Xtalpi Inc.


Recent Progress in Immuno-Oncology

Tong-Tong Xue, PhD, CEO of Kelun Bo-Tai Biological Company and Vice President of Kelun Pharmaceutical Research Institute


3:00 pm - 3:30 pm     COFFEE BREAK AND VENDOR SHOW


3:30 pm – 5:30 pm     SESSION III - INVESTMENT ACROSS BORDERS


From Entrepreneur to Investor: A Novel Way to Experience Inorganic Business

Johnson Zhang, MBA, Vice President & General Manager, Perkin Elmer APAC


Leveraging Collaboration and In Kind as Non-Dilutive Investments

Jae Sly, PhD, MBA, Director of Strategic Business Development, ACROBiosystems


Venture Creation of Cross-Border Life Sciences Companies

Cheryl Cui, PhD, Partner, Nest. Bio Ventures, Venture Partner, Venture Health


Entrepreneurship From the US to China and Back, a Personal Journey

Alex Wu, PhD, MBA, Partner, Green Pine Capital Partners


Sailing Westward by China Biopharm Firms

Sean Fu, PhD, Vice President of Luye Global R&D, President of Luye Boston R&D   


6:00 pm - 9:00 pm          SESSION IV - DINNER RECEPTION

6:00 pm - 6:45 pm          KEYNOTE Presentation: CRISPR Screens and Big Data Mining for Precision Cancer

Medicine

Xiaole Shirley Liu, PhD, Professor of Statistics, Biostatistics, and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health


6:45 pm - 7:30 pm        CABA ANNOUNCEMENT

7:30 pm - 9:00 pm        SOCIAL AND NETWORKING








Organizer:

Chinese-American BioMedical Association

View other events by the organizer

Date Time

2018-05-19 08:00 - Start

2018-05-19 21:00 - End

Ended
Address
  • Boston Marriott Newton, 2345 Commonwealth Avenue , NEWTON  MA  02466